4-[2-(5-氯-2-甲氧基苯甲酰胺)-乙基]-苯磺酰胺(格列本脲杂质Ⅰ) 标准品
| 英文名称 | 5-Chloro-2- methoxy-N-[2-(4-sulphamoylphenyl |
| 储存条件 | RT,避光 |
| 规格 | 50mg |
4-[2-(5-氯-2-甲氧基苯甲酰胺)-乙基]-苯磺酰胺(格列本脲杂质Ⅰ) 标准品
| 英文名称 | 5-Chloro-2- methoxy-N-[2-(4-sulphamoylphenyl |
| 储存条件 | RT,避光 |
| 规格 | 50mg |
4-[2-[3-乙基-4-甲基-2-氧代-3-吡咯啉-1-甲酰胺基]乙基]苯磺酰胺(格列美脲杂质2) 标准品
| 规格 | 50mg |
AK-7;N-(3-溴苯基)-3-[(六氢-1H-氮杂卓-1-基)磺酰基]-苯甲酰胺
| MDL | MFCD03140195 |
| InChIKey | IYAYHZZWYNXHEQ-UHFFFAOYSA-N |
| InChI | InChI=1S/C19H21BrN2O3S/c20-16-8-6-9-17(14-16)21-19(23)15-7-5-10-18(13-15)26(24,25)22-11-3-1-2-4-12-22/h5-10,13-14H,1-4,11-12H2,(H,21,23) |
| PubChem CID | 1328033 |
| 别名 | N-(3-溴苯基)-3-[(六氢-1H-氮杂卓-1-基)磺酰基]-苯甲酰胺 |
| CAS | 420831-40-9 |
| 分子式 | C19H21BrN2O3S |
| 分子量 | 437.35 |
| 储存条件 | -20℃ |
| 纯度 | ≥98% |
| 单位 | 瓶 |
| SMILES | O=S(N1CCCCCC1)(C2=CC(C(NC3=CC(Br)=CC=C3)=O)=CC=C2)=O |
| 靶点 | SIRT2 |
| 规格 | 5mg 10mg |
4-氨基-5-咪唑甲酰胺
| EC | EINECS 206-641-4 |
| MDL | MFCD02181040 |
| 描述 | 是合成嘌呤的重要前体,尤其是核碱基腺嘌呤和鸟嘌呤。 |
| InChIKey | DVNYTAVYBRSTGK-UHFFFAOYSA-N |
| InChI | InChI=1S/C4H6N4O/c5-3-2(4(6)9)7-1-8-3/h1H,5H2,(H2,6,9)(H,7,8) |
| PubChem CID | 9679 |
| 别名 | 5-氨基-1H-咪唑-4-甲酰胺;替莫唑胺氨基咪唑杂质 |
| 英文名称 | 4-Amino-5-imidazolecarboxamide |
| CAS | 360-97-4 |
| 分子式 | C4H6N4O |
| 分子量 | 126.12 |
| 纯度 | ≥98% |
| 单位 | 瓶 |
| SMILES | O=C(C1=C(N)NC=N1)N |
| 靶点 | Others |
| 规格 | 500mg 1g |
是合成嘌呤的重要前体。
N-羟基-2-[(1-苯基环丙基)氨基]-5-嘧啶甲酰胺
| MDL | MFCD28347706 |
| 别名 | ACY738 |
| 英文名称 | ACY-738 |
| CAS | 1375465-91-0 |
| 分子式 | C14H14N4O2 |
| 分子量 | 270.29 |
| 纯度 | ≥98% |
| 单位 | 瓶 |
| SMILES | O=C(NO)C(C=N1)=CN=C1NC2(CC2)C3=CC=CC=C3 |
| 靶点 | HDAC |
| 规格 | 10mM*1mL (in DMSO) 5mg 10mg |
4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺
| MDL | MFCD00348720 |
| 别名 | RAD51-stimulatorycompound1 |
| 英文名称 | RS-1 |
| CAS | 312756-74-4 |
| 分子式 | C20H16Br2N2O3S |
| 分子量 | 524.23 |
| 纯度 | ≥98% |
| 单位 | 瓶 |
| In Vitro | RS-1 is a RAD51 activator, stimulating binding of hRAD51 to DNA with Kd ranging from 48 nM to 107 nM in the presence of ATP or ADP and in the absence of a nucleotide cofactor, and such an effect is not via inhibiting its ATPase activity. RS-1 (20 μM) affects the length and helical pitch of hRAD51 protein-DNA complexes. RS-1 (0, 1, 5, 10, 15, 20, and 25 μM) stimulates strand assimilation activity of hRAD51. RS-1 (7.5 μM) promotes resistance of human cells to cross-linking chemotherapy[1]. RS-1 (0, 7.5, 15 μM) increases Cas9-mediated knock-in efficiencies in rabbit embryos[2]. |
| 激酶实验 | Briefly, 15 μL reaction volumes include a DNA strand exchange protein (0.8 μM) that is preincubated for 5 min at 37°C with 1 μM (nucleotide concentration) 32P-labeled oligonucleotide 306.7 in a reaction buffer containing 20 mM Hepes (pH 7.5), 1 mM DTT, 2 mM nucleotide cofactor, and 1 mM MgCl2 and various concentrations of RS-1. For experimental buffer conditions that included calcium, 1 mM CaCl2 is present in addition to (in the case of hRAD51) or in the place of (in the case of RecA and scRAD51) the 1 mM MgCl2. Conditions with scRAD51 additionally contains 110 nM scRAD54. After this initial binding reaction, 10 μL of 19.75 μM (base pair concentration) supercoiled homologuecontaining target plasmid DNA (pRS306) is next added along with sufficient magnesium acetate to give a final concentration of 10 mM[1]. |
| 货期 | 1-2天 |
| SMILES | O=C(NC1=CC=C(Br)C=C1)C2=CC=C(Br)C(S(=O)(NCC3=CC=CC=C3)=O)=C2 |
| 靶点 | RAD51 |
| 数据来源文献 | [1]. Jayathilaka K, et al. A chemical compound that stimulates the human homologous recombination protein RAD51. Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15848-53. [2]. Song J, et al. RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency. Nat Commun. 2016 Jan 28;7:10548. |
| 规格 | 5mg 10mM*1mL (in DMSO) 10mg |
RS-1 是一种 RAD51 的激活剂,同时可增强 CRISPR/Cas9 的活性。
来氟米特杂质Ⅲ{3-甲基-N-[4-(三氟甲基)苯基]异恶唑-4-甲酰胺}
| 英文名称 | Leflunomide impurityⅢ{3-Methyl-N-[4-(trifluoromethyl)ph enyl]isoxazole-4-carboxamide} |
| CAS | 208401-20-1 |
| 储存条件 | RT |
| 单位 | 瓶 |
| 规格 | 25ug |
碘佛醇杂质Ⅱ(N,N’-双(2,3-二羟丙基)-5-(2-(2-羟乙酰胺基)-2-氧代乙氧基)- 2,4,6-三碘-1,3-苯二甲酰胺)
| 英文名称 | Ioversol impurityⅡ(N,N’-bis(2,3-dihydroxypropyl)-5-(2-(2- hydroxyethylamino)-2-oxoethoxy)-2, 4,6-triiodoisophthalamide) |
| CAS | 104517-96-6 |
| 储存条件 | RT |
| 单位 | 瓶 |
| 规格 | 50mg |
格列美脲杂质Ⅱ 4-[2-[3-乙基-4-甲基-2-氧代-3-吡咯啉-1-甲酰胺基]乙基]苯磺酰胺基甲酸甲酯
| 英文名称 | Glimepiride Impurity Ⅱ [[4-[2-[3-ethyl-4-methyl-2-oxo-3-pyrro line-1-carboxamido]ethyl]phenyl]su lfonyl]methyl carbamate |
| CAS | 119018-30-3 |
| 储存条件 | 2-8℃ |
| 单位 | 瓶 |
| 规格 | 30mg |
3-氯-N-[2-氧代-2-[[(1S)-1-苯基乙基]氨基]乙基]苯甲酰胺
| MDL | MFCD29924732 |
| 别名 | JNJ63533054;JNJ63533054 |
| 英文名称 | JNJ-63533054 |
| CAS | 1802326-66-4 |
| 分子式 | C17H17ClN2O2 |
| 分子量 | 316.78 |
| 纯度 | ≥98% |
| 单位 | 瓶 |
| 货期 | 1-2天 |
| SMILES | O=C(NCC(N[C@H](C1=CC=CC=C1)C)=O)C2=CC=CC(Cl)=C2 |
| 靶点 | GPR139 |
| 规格 | 5mg 10mM*1mL (in DMSO) 10mg |